Bioventus (BVS) Non-Current Debt (2020 - 2026)

Bioventus (BVS) has 7 years of Non-Current Debt data on file, last reported at $253.3 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Debt fell 17.91% year-over-year to $253.3 million; the trailing twelve-month figure through Mar 2026 stood at $253.3 million (down 17.91% YoY), and the FY2025 full-year result was $279.0 million, down 9.52% from the prior year.
• Non-Current Debt for Q1 2026 stood at $253.3 million, down from $279.0 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $404.3 million in Q2 2023 and bottomed at $253.3 million in Q1 2026.
• The 5-year median for Non-Current Debt is $348.0 million (2022), against an average of $341.3 million.
• The widest annual swing landed in 2022, when Non-Current Debt jumped 142.0%; it then retreated 17.91% in 2026.
• A 5-year view of Non-Current Debt shows it stood at $385.0 million in 2022, then declined by 4.68% to $367.0 million in 2023, then slipped by 16.0% to $308.3 million in 2024, then slipped by 9.52% to $279.0 million in 2025, then retreated by 9.19% to $253.3 million in 2026.
• The last three Non-Current Debt figures came in at $253.3 million (Q1 2026), $279.0 million (Q4 2025), and $311.3 million (Q3 2025), per Business Quant data.

Peer Comparison